Mercapto mix in patch testing
Malin Engfeldt, Marléne Isaksson, Bo Glas, Lina Hagvall, Anna Löfnertz Petersson, Mihály Matura, et al.
The authors of this study recommend replacing mercaptobenzothiazole mix 2.0% with mercaptobenzothiazole mix 3.5%.
Burden of atopic dermatitis in Sweden: a population-based study
Grigorios Theodosiou, Scott Montgomery, Alexandra Metsini, Florence J. Dalgard, Åke Svensson, Laura B. von Kobyletzki
The results in this study suggest that AD implies an increased prevalence of comorbid mental conditions and an adverse impact on academic achievement and work.
Cutaneous disorders and Castleman’s disease
Hyo Jung Kim, Ju Hee Han, Chul Hwan Bang, Kyung Shin Park, Seok-Goo Cho, Dong Su Yoo, et al.
The study highlights the role of dermatologists in an indepth review of various skin disorders related to Castelman's disease.
Sirolimus for vascular anomalies: a multicentre study and review
Shira Sandbank, Vered Molho-Pessach, Adam Farkas, Aviv Barzilai, Shoshana Greenberger
Sirolimus appears to be an effective and safe treatment for children and young adults with complicated vascular anomalies.
Corticosteroid phobia among healthcare professionals
Lies Lambrechts, Liesbeth Gilissen, Marie-Anne Morren
There is prominent corticophobia among healthcare professionals, especially among pharmacists and general practitioners, probably based on insufficient knowledge of topical corticosteroids. In order to improve patient compliance, re-eduation of healthcare providers is suggested.
Itch in elderly people
Radomir Reszke, Rafał Białynicki-Birula, Karolina Lindner, Małgorzata Sobieszczańska, Jacek C. Szepietowski
The results of this study support the role of an interdisciplinary diagnostic and therapeutic approach to elderly patients with chronic itch.
Validation of psoriasis diagnoses in Danish national patient register
Nikolai Dyrberg Loft, Christian Harbo Andersen, Anne-Sofie Halling-Overgaard, Jacob P. Thyssen, Lone Skov, Alexander Egeberg
This tudy suggests that the use of the ICD-10 code L40.0 to identify patients with psoriasis is a valid approach in registry-based studies.